Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens

Jayastu Senapati; Tareq Abuasab; Fadi G. Haddad; Farhad Ravandi; Tapan Kadia; Courtney DiNardo; Naval Daver; Naveen Pemmaraju; Yesid Alvarado; Mark A. Brandt; Hagop Kantarjian; Gautam Borthakur

doi:10.1002/ajh.26811

Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens

Jayastu Senapati, Tareq Abuasab, Fadi G. Haddad, Farhad Ravandi, Tapan Kadia, Courtney DiNardo, Naval Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A. Brandt, Hagop Kantarjian, Gautam Borthakur

Leukemia

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	E53-E56
Journal	American journal of hematology
Volume	98
Issue number	3
DOIs	https://doi.org/10.1002/ajh.26811
State	Published - Mar 1 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.26811

Cite this

Senapati, J., Abuasab, T., Haddad, F. G., Ravandi, F., Kadia, T., DiNardo, C., Daver, N., Pemmaraju, N., Alvarado, Y., Brandt, M. A., Kantarjian, H., & Borthakur, G. (2023). Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology, 98(3), E53-E56. https://doi.org/10.1002/ajh.26811

Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. / Senapati, Jayastu; Abuasab, Tareq; Haddad, Fadi G. et al.
In: American journal of hematology, Vol. 98, No. 3, 01.03.2023, p. E53-E56.

Research output: Contribution to journal › Letter › peer-review

Senapati, J, Abuasab, T, Haddad, FG , Ravandi, F , Kadia, T , DiNardo, C , Daver, N , Pemmaraju, N , Alvarado, Y, Brandt, MA, Kantarjian, H & Borthakur, G 2023, 'Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens', American journal of hematology, vol. 98, no. 3, pp. E53-E56. https://doi.org/10.1002/ajh.26811

@article{c41b817d1a3a433d9f483f2b70d509af,

title = "Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens",

author = "Jayastu Senapati and Tareq Abuasab and Haddad, {Fadi G.} and Farhad Ravandi and Tapan Kadia and Courtney DiNardo and Naval Daver and Naveen Pemmaraju and Yesid Alvarado and Brandt, {Mark A.} and Hagop Kantarjian and Gautam Borthakur",

year = "2023",

month = mar,

day = "1",

doi = "10.1002/ajh.26811",

language = "English (US)",

volume = "98",

pages = "E53--E56",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens

AU - Senapati, Jayastu

AU - Abuasab, Tareq

AU - Haddad, Fadi G.

AU - Ravandi, Farhad

AU - Kadia, Tapan

AU - DiNardo, Courtney

AU - Daver, Naval

AU - Pemmaraju, Naveen

AU - Alvarado, Yesid

AU - Brandt, Mark A.

AU - Kantarjian, Hagop

AU - Borthakur, Gautam

PY - 2023/3/1

Y1 - 2023/3/1

UR - http://www.scopus.com/inward/record.url?scp=85148113686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148113686&partnerID=8YFLogxK

U2 - 10.1002/ajh.26811

DO - 10.1002/ajh.26811

M3 - Letter

C2 - 36565294

AN - SCOPUS:85148113686

SN - 0361-8609

VL - 98

SP - E53-E56

JO - American journal of hematology

JF - American journal of hematology

IS - 3

ER -

Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this